Form 4: Centessa Pharmaceuticals' General Counsel, Iqbal Hussain, Reports Changes in Beneficial Ownership

Iqbal Hussain, General Counsel of Centessa Pharmaceuticals, reports the disposal of 7,520 ordinary shares to cover tax obligations and discloses beneficial ownership of 205,010 ordinary shares directly and 5,500 indirectly through a spouse.

Summary

• On June 30, 2024, Iqbal Hussain, the General Counsel of Centessa Pharmaceuticals plc, reported a transaction involving the company's ordinary shares.
• Mr. Hussain disposed of 7,520 ordinary shares at a price of $9.03 per share to cover tax withholding obligations related to the vesting of restricted share units.
• Following this transaction, Mr. Hussain directly owns 205,010 ordinary shares and indirectly owns 5,500 ordinary shares through his spouse.

Sentiment

Score: 5

Explanation: This is a neutral report of a routine transaction. It doesn't indicate positive or negative sentiment about the company's performance.

Industry Context

This is a standard SEC Form 4 filing, which is a routine disclosure required when company insiders, like the General Counsel, trade in their company's stock. It provides transparency to the market about the transactions of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders.
• The transactions reported are typical for covering tax obligations related to vesting of restricted stock units, which is a common form of executive compensation.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it is a routine disposal of shares for tax obligations.

Key Dates